{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:40:27Z","timestamp":1794008427613,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Emerging evidence has suggested a close correlation between COVID-19 and neurodegenerative disorders. However, whether there exists a causal association and the effect direction remains unknown. To examine the causative role of COVID-19 in the risk of neurodegenerative disorders, we estimated their genetic correlation, and then conducted a two-sample Mendelian randomization analysis using summary statistics from genome-wide association studies of susceptibility, hospitalization, and severity of COVID-19, as well as six major neurodegenerative disorders including Alzheimer\u2019s disease (AD), amyotrophic lateral sclerosis, frontotemporal dementia, Lewy body dementia, multiple sclerosis, and Parkinson\u2019s disease. We identified a significant and positive genetic correlation between hospitalization of COVID-19 and AD (genetic correlation: 0.23,<jats:italic>P<\/jats:italic>\u2009=\u20098.36E\u201307). Meanwhile, hospitalization of COVID-19 was significantly associated with a higher risk of AD (OR: 1.02, 95% CI: 1.01\u20131.03,<jats:italic>P<\/jats:italic>: 1.19E\u201303). Consistently, susceptibility (OR: 1.05, 95% CI: 1.01\u20131.09,<jats:italic>P<\/jats:italic>: 9.30E\u201303) and severity (OR: 1.01, 95% CI: 1.00\u20131.02,<jats:italic>P<\/jats:italic>: 0.012) of COVID-19 were nominally associated with higher risk of AD. The results were robust under all sensitivity analyses. These results demonstrated that COVID-19 could increase the risk of AD. Future development of preventive or therapeutic interventions could attach importance to this to alleviate the complications of COVID-19.<\/jats:p>","DOI":"10.1038\/s41398-022-02052-3","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T14:05:44Z","timestamp":1657807544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study"],"prefix":"10.1038","volume":"12","author":[{"given":"Chunyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-1151","authenticated-orcid":false,"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"2052_CR1","first-page":"133","volume":"325","author":"HK Koh","year":"2021","unstructured":"Koh HK, Geller AC, VanderWeele TJ. Deaths from COVID-19. Jama. 2021;325:133\u20134.","journal-title":"Jama"},{"key":"2052_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683\u201390.","journal-title":"JAMA Neurol"},{"key":"2052_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220\u201332.","journal-title":"Lancet"},{"key":"2052_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/alz.12556","volume":"18","author":"JA Frontera","year":"2022","unstructured":"Frontera JA, Boutajangout A, Masurkar AV, Betensky RA, Ge Y, Vedvyas A, et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer\u2019s dementia. Alzheimer\u2019s Dementia: J Alzheimeras Assoc. 2022;18:899\u2013910.","journal-title":"Alzheimer\u2019s Dementia: J Alzheimeras Assoc"},{"key":"2052_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","volume":"8","author":"M Taquet","year":"2021","unstructured":"Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416\u201327.","journal-title":"Lancet Psychiatry"},{"key":"2052_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/d41586-020-02599-5","volume":"585","author":"M Marshall","year":"2020","unstructured":"Marshall M. How COVID-19 can damage the brain. Nature. 2020;585:342\u20133.","journal-title":"Nature"},{"key":"2052_CR7","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA. 2020;117:11727\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/WCO.0000000000000944","volume":"34","author":"SF Farhadian","year":"2021","unstructured":"Farhadian SF, Seilhean D, Spudich S. Neuropathogenesis of acute coronavirus disease 2019. Curr Opin Neurol. 2021;34:417\u201322.","journal-title":"Curr Opin Neurol"},{"key":"2052_CR9","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41422-020-0390-x","volume":"30","author":"B-Z Zhang","year":"2020","unstructured":"Zhang B-Z, Chu H, Han S, Shuai H, Deng J, Hu Y-F, et al. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30:928\u201331.","journal-title":"Cell Res"},{"key":"2052_CR10","doi-asserted-by":"publisher","first-page":"e20202135.","DOI":"10.1084\/jem.20202135","volume":"218","author":"E Song","year":"2021","unstructured":"Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218:e20202135.","journal-title":"J Exp Med"},{"key":"2052_CR11","doi-asserted-by":"publisher","first-page":"872134.","DOI":"10.3389\/fnagi.2022.872134","volume":"14","author":"X Zang","year":"2022","unstructured":"Zang X, Chen S, Zhu J, Ma J, Zhai Y. The emerging role of central and peripheral immune systems in neurodegenerative diseases. Front Aging Neurosci. 2022;14:872134.","journal-title":"Front Aging Neurosci"},{"key":"2052_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fncel.2019.00355","volume":"13","author":"A Fani Maleki","year":"2019","unstructured":"Fani Maleki A, Rivest S. Innate immune cells: Monocytes, monocyte-derived macrophages, and microglia as therapeutic targets for Alzheimer\u2019s disease and multiple sclerosis. Front Cell Neurosci. 2019;13:355.","journal-title":"Front Cell Neurosci"},{"key":"2052_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41583-020-0263-9","volume":"21","author":"AD Greenhalgh","year":"2020","unstructured":"Greenhalgh AD, David S, Bennett FC. Immune cell regulation of glia during CNS injury and disease. Nat Rev Neurosci. 2020;21:139\u201352.","journal-title":"Nat Rev Neurosci"},{"key":"2052_CR14","doi-asserted-by":"publisher","first-page":"e041471","DOI":"10.1136\/bmjopen-2020-041471","volume":"10","author":"QQ Liu","year":"2020","unstructured":"Liu QQ, Cheng A, Wang Y, Li H, Hu L, Zhao X, et al. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): A retrospective cohort study. BMJ Open. 2020;10:e041471.","journal-title":"BMJ Open"},{"key":"2052_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fncel.2017.00216","volume":"11","author":"D Kempuraj","year":"2017","unstructured":"Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, et al. Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front Cell Neurosci. 2017;11:216.","journal-title":"Front Cell Neurosci"},{"key":"2052_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918\u201334.","journal-title":"Cell"},{"key":"2052_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-45","volume":"5","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Tansey MG. TNF signaling inhibition in the CNS: Implications for normal brain function and neurodegenerative disease. J Neuroinflammation. 2008;5:45.","journal-title":"J Neuroinflammation"},{"key":"2052_CR18","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S1474-4422(21)00168-X","volume":"20","author":"J Pratt","year":"2021","unstructured":"Pratt J, Lester E, Parker R. Could SARS-CoV-2 cause tauopathy? Lancet Neurol. 2021;20:506.","journal-title":"Lancet Neurol"},{"key":"2052_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25015-6","volume":"12","author":"P Pan","year":"2021","unstructured":"Pan P, Shen M, Yu Z, Ge W, Chen K, Tian M, et al. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nat Commun. 2021;12:4664.","journal-title":"Nat Commun"},{"key":"2052_CR20","doi-asserted-by":"publisher","first-page":"e20201707.","DOI":"10.1084\/jem.20201707","volume":"218","author":"TS Rodrigues","year":"2021","unstructured":"Rodrigues TS, de S\u00e1 KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2021;218:e20201707.","journal-title":"J Exp Med"},{"key":"2052_CR21","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/alz.12352","volume":"17","author":"AC Tahira","year":"2021","unstructured":"Tahira AC, Verjovski-Almeida S, Ferreira ST. Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients. Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc. 2021;17:1818\u20131831.","journal-title":"Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc"},{"key":"2052_CR22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/mds.28170","volume":"35","author":"R Cilia","year":"2020","unstructured":"Cilia R, Bonvegna S, Straccia G, Andreasi NG, Elia AE, Romito LM, et al. Effects of COVID-19 on Parkinson\u2019s disease clinical features: A community-based case-control study. Mov Disord: Off J Mov Disord Soc. 2020;35:1287\u201392.","journal-title":"Mov Disord: Off J Mov Disord Soc"},{"key":"2052_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.tins.2020.10.009","volume":"43","author":"P Brundin","year":"2020","unstructured":"Brundin P, Nath A, Beckham JD. Is COVID-19 a perfect storm for Parkinson\u2019s disease? Trends Neurosci. 2020;43:931\u20133.","journal-title":"Trends Neurosci"},{"issue":"15 Suppl","key":"2052_CR24","doi-asserted-by":"crossref","first-page":"5032.","DOI":"10.1212\/WNL.96.15_supplement.5032","volume":"96","author":"S Lee","year":"2021","unstructured":"Lee S, Arcila-Londono X, Steijlen K, Newman D, Grover K. Case report of ALS patient with COVID-19 infection (5032). Neurology. 2021;96 15 Suppl:5032.","journal-title":"Neurology"},{"key":"2052_CR25","doi-asserted-by":"publisher","first-page":"724022.","DOI":"10.3389\/fpsyg.2021.724022","volume":"12","author":"JA Matias-Guiu","year":"2021","unstructured":"Matias-Guiu JA, Delgado-Alonso C, Yus M, Polidura C, G\u00f3mez-Ruiz N, Valles-Salgado M, et al. \u201cBrain Fog\u201d by COVID-19 or Alzheimer\u2019s disease? A case report. Front Psychol. 2021;12:724022.","journal-title":"Front Psychol"},{"key":"2052_CR26","doi-asserted-by":"crossref","unstructured":"The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Eur J Human Gen: EJHG. 2020;28:715\u20138.","DOI":"10.1038\/s41431-020-0636-6"},{"key":"2052_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51:404\u201313.","journal-title":"Nat Genet"},{"key":"2052_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091\u2013102.","journal-title":"Lancet Neurol"},{"key":"2052_CR29","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.neuron.2018.02.027","volume":"97","author":"A Nicolas","year":"2018","unstructured":"Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268\u20131283.e1266.","journal-title":"Neuron"},{"key":"2052_CR30","unstructured":"International Multiple Sclerosis Genetics Consortium. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365:eaav7188."},{"key":"2052_CR31","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1474-4422(14)70065-1","volume":"13","author":"R Ferrari","year":"2014","unstructured":"Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, et al. Frontotemporal dementia and its subtypes: A genome-wide association study. Lancet Neurol. 2014;13:686\u201399.","journal-title":"Lancet Neurol"},{"key":"2052_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, et al. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet. 2021;53:294\u2013303.","journal-title":"Nat Genet"},{"key":"2052_CR33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ajhg.2017.11.001","volume":"101","author":"Q Lu","year":"2017","unstructured":"Lu Q, Li B, Ou D, Erlendsdottir M, Powles RL, Jiang T, et al. A powerful approach to estimating annotation-stratified genetic covariance via GWAS summary statistics. Am J Hum Genet. 2017;101:939\u201364.","journal-title":"Am J Hum Genet"},{"key":"2052_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey, Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304\u201314.","journal-title":"Genet Epidemiol"},{"key":"2052_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"2052_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u201389.","journal-title":"Eur J Epidemiol"},{"key":"2052_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/gepi.21998","volume":"40","author":"S Burgess","year":"2016","unstructured":"Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40:597\u2013608.","journal-title":"Genet Epidemiol"},{"key":"2052_CR38","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"MJ Brion","year":"2013","unstructured":"Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42:1497\u2013501.","journal-title":"Int J Epidemiol"},{"key":"2052_CR39","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7:e34408.","DOI":"10.7554\/eLife.34408"},{"key":"2052_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2215-0366(20)30203-0","volume":"7","author":"JP Rogers","year":"2020","unstructured":"Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611\u201327.","journal-title":"Lancet Psychiatry"},{"key":"2052_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13195-020-00744-w","volume":"12","author":"S Miners","year":"2020","unstructured":"Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: Looking beyond the short term. Alzheimer\u2019s Res Ther. 2020;12:170.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2052_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jpsychires.2020.06.022","volume":"129","author":"H Zhou","year":"2020","unstructured":"Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, et al. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020;129:98\u2013102.","journal-title":"J Psychiatr Res"},{"key":"2052_CR43","doi-asserted-by":"crossref","unstructured":"Park HY, Song IA, Oh TK. Dementia risk among coronavirus disease survivors: A nationwide cohort study in South Korea. J Personalized Med. 2021;11:1015.","DOI":"10.3390\/jpm11101015"},{"key":"2052_CR44","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/alz.12255","volume":"17","author":"GA de Erausquin","year":"2021","unstructured":"de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimer\u2019s Dement: J Alzheimer\u2019s Assoc. 2021;17:1056\u201365.","journal-title":"Alzheimer\u2019s Dement: J Alzheimer\u2019s Assoc"},{"key":"2052_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/alz.12558","volume":"18","author":"S Reiken","year":"2022","unstructured":"Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer\u2019s-like signaling in brains of COVID-19 patients. Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc. 2022;18:955\u2013965.","journal-title":"Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc"},{"key":"2052_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13195-020-00640-3","volume":"12","author":"MT Heneka","year":"2020","unstructured":"Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer\u2019s Res Ther. 2020;12:69.","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"2052_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13195-021-00850-3","volume":"13","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Xu J, Hou Y, Leverenz JB, Kallianpur A, Mehra R, et al. Network medicine links SARS-CoV-2\/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimer\u2019s Res Ther. 2021;13:110.","journal-title":"Alzheimer\u2019s Res Ther"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02052-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02052-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02052-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T04:17:35Z","timestamp":1727583455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02052-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02052-3","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"5 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}